Mometasona Furoato Vir (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Furoato Vir, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal allergic rhinitis and nasal polyps in adults and children as appropriate.

GNH USA supplies Mometasona Furoato Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching and sneezing. Seasonal allergic rhinitis: provides relief of seasonal nasal symptoms. Nasal polyps: helps shrink polyps and improve nasal airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Cough - Altered taste or bitter taste

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic fungal infection of the nasal cavity

Before using Mometasone furoate nasal spray, consider the following precautions. - Hypersensitivity: avoid if known allergy to mometasone or any formulation component. - Recent nasal surgery or trauma: use only under medical guidance. - Untreated fungal infection of the nose: do not use until resolved. - Systemic corticosteroid use: monitor for additive systemic effects. - Children: use the lowest effective dose and follow pediatric guidance. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines; awareness helps minimize risk.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) – may increase systemic exposure. - Concurrent use of other nasal corticosteroids – raises risk of local adverse effects. - Systemic immunosuppressants – may enhance infection risk.

Moderate Interactions (Monitor Closely): - Oral or inhaled corticosteroids – monitor for signs of systemic glucocorticoid excess. - Antifungal nasal agents – assess for additive local irritation. - Antihistamines – may increase sedation in sensitive individuals.